Viroxis
A biopharmaceutical company developing botanical pharmaceuticals for the treatment of human papillomavirus infections
2
Funding Rounds
$10.3m
Money raised
Funding
Funding series
Funding Series Analysis
The company Viroxis has raised a total of $10.3m in funding over 2 rounds.
Key Insights:
- Viroxis funding round, April 2013: $7.8m
- Viroxis Series A round: $2.5m
Viroxis funding round, April 2013
$7.8m
Viroxis Series A round
$2.5m